Assembly Biosciences (ASMB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2018 | 06-2018 | 03-2018 | 12-2017 | 09-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 119,752 | 54,192 | 66,927 | 82,033 | 27,247 |
| Marketable Securities | 114,188 | 38,480 | 42,232 | 37,914 | 39,053 |
| Receivables | 2,590 | 2,126 | 2,264 | 2,274 | 1,400 |
| TOTAL | $239,873 | $97,529 | $113,226 | $123,119 | $68,652 |
| Non-Current Assets | |||||
| PPE Net | 516 | 640 | 732 | 860 | 593 |
| Investments And Advances | 0 | 2,204 | 0 | 3,347 | 1,004 |
| Intangibles | 41,638 | 41,638 | 41,638 | 41,638 | 41,638 |
| Other Non-Current Assets | 951 | 407 | 426 | 340 | 426 |
| TOTAL | $43,105 | $44,889 | $42,795 | $46,185 | $43,661 |
| Total Assets | $282,977 | $142,418 | $156,021 | $169,304 | $112,313 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,988 | 2,539 | 2,373 | 2,124 | 871 |
| Accrued Expenses | 6,517 | 5,080 | 4,648 | 6,139 | 6,353 |
| TOTAL | $14,610 | $13,131 | $12,180 | $13,492 | $12,219 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 5,105 | 5,512 | 5,160 | 5,229 | 4,996 |
| TOTAL | $38,934 | $40,187 | $41,460 | $42,692 | $52,961 |
| Total Liabilities | $53,544 | $53,318 | $53,640 | $56,184 | $65,180 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 2,121 | 2,120 | 1,712 | 1,687 | 1,449 |
| Common Shares | 26 | 21 | 20 | 20 | 17 |
| Retained earnings | -315,626 | -294,091 | -267,285 | -251,036 | -248,029 |
| Other shareholders' equity | -355 | -372 | -459 | -392 | -388 |
| TOTAL | $229,433 | $89,101 | $102,381 | $113,120 | $47,133 |
| Total Liabilities And Equity | $282,977 | $142,418 | $156,021 | $169,304 | $112,313 |